BIOCONNSEBiocon Limited· PharmaceuticalsMinimalNeutral
Announced Tue, 11 Nov · 20:57 IST

Monitoring Agency Report for the quarter ended on September 30, 2025

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Biocon Limited has submitted the Monitoring Agency Report for the quarter ended September 30, 2025, to the stock exchanges as required under SEBI regulations. This report is typically filed when a company has raised funds through a Qualified Institutional Placement (QIP), preferential issue, or rights issue exceeding ₹100 crore. The monitoring agency tracks and certifies whether the company is using the proceeds from the fundraise strictly for the purposes disclosed in the original offer document. The filing confirms compliance with disclosure norms but does not itself signal any material change or event for the company.

Likely market impact

This is a routine regulatory compliance filing with no direct bearing on the stock price. Shareholders should check the actual report (available on NSE/BSE) to confirm that the company is using raised funds as originally stated, which is a healthy governance signal if usage matches stated objectives.